Why Menopause and Eldercare Just Became Board-Level Governance Issues

Executive Summary

Ten years ago, if you'd told a board that menopause and eldercare belonged on the same agenda as cybersecurity or executive pay, most directors would have laughed you out of the room. Nobody's laughing now. New disclosure rules, evolving employment laws, and a workforce where caregiving responsibilities increasingly overlap with peak leadership years have made menopause and eldercare governance an important part of corporate governance. These issues are moving beyond HR policy documents into board-level discussions around human capital oversight, workforce retention, and legal compliance. This article explores why this shift is happening, what the data reveals, and what boards should be asking to address caregiving as a business and governance priority.

Quick Answer:

Why Is Caregiving Policy a Governance Issue Now?

Because it touches three things boards are formally accountable for: talent retention at the senior level, human capital disclosure obligations, and legal exposure across a fast-changing patchwork of state and national laws. Menopause and eldercare aren't just personal circumstances anymore, they're workforce risks with a price tag attached, and that price tag is exactly what pulls an issue from HR's desk onto the board's.

What's Driving Menopause and Eldercare Onto the Board Agenda?

Start with the scale of who's affected. Close to 20 percent of the US female workforce sits in the 45 to 54 age bracket, precisely where menopause symptoms tend to peak. On the eldercare side, roughly 24 million employed Americans are simultaneously acting as informal caregivers for an aging relative, and that number is only going to grow as the 65-plus population, already at nearly 60 million, is projected to cross 20 percent of the total US population by 2035.

Who does this hit hardest? Ironically, some of the most experienced people in the workforce, the ones in their late 40s and 50s who are often just reaching senior leadership roles. What does it cost? A lot more than most boards assume. Eldercare alone is estimated to cost US employers somewhere between $17 billion and $34 billion a year in lost productivity, and unpaid family caregiving nationally adds up to more than $1 trillion annually, more than the entire US Medicaid budget. A widely cited Mayo Clinic study of over 4,400 working women aged 45 to 60 found that 13.4 percent reported an adverse work outcome directly tied to menopause symptoms, things like reduced hours, missed promotions, or leaving a role altogether.

Why is this becoming a governance conversation specifically, rather than staying an HR one? Because the regulatory ground has shifted under everyone's feet in the past two years. The UK's Employment Rights Act 2025 has pushed menopause support from a nice-to-have wellbeing perk toward a formal compliance requirement, with menopause action plans becoming mandatory for larger employers. In the US, Rhode Island became the first state to add menopause to its protected categories under fair employment law in June 2025, and other states and cities have since followed with their own versions. Layer on top of that the SEC's human capital disclosure rule, which has required US public companies to describe their human capital resources and management approach in annual filings since 2020, and you get a situation where caregiving policy isn't just a culture question anymore, it's something investors and regulators are explicitly looking for a company to address.

Real-World Example: The Regulatory Shift Is Already Here

The UK's move from voluntary to mandatory

Under the Employment Rights Act 2025, menopause action plans became voluntary for UK employers starting in April 2026, with mandatory adoption expected for companies with 250 or more employees likely from spring 2027. That's a meaningful shift, it takes menopause support out of the realm of optional employee benefit and turns it into something a board has to be able to point to, in writing, if asked. Employers are also now under a health and safety obligation to formally assess workplace risks related to menopause, which is a very different standard than simply offering a wellness webinar once a year.

What the disclosure data shows in the US

Meanwhile, in the US, a review of S&P 100 human capital disclosures found that references to board-level oversight of human capital issues rose from an average of 35 percent of companies in 2021 to 42 percent in 2022, and that upward trend has continued as the SEC's principles-based rule matures and investors get more specific about what they expect to see. Put those two data points side by side and the picture is clear: on both sides of the Atlantic, disclosure and compliance expectations around workforce caregiving issues are tightening, not staying flat.

The Boardroom View

It's tempting to file this under diversity and inclusion, or under general employee wellness, and move on. That undersells what's actually happening. This is fundamentally a talent-retention and disclosure-risk conversation. The employees most affected by menopause and eldercare responsibilities are disproportionately the same people companies have spent years and significant budget developing into senior leaders. Losing them, or watching their performance quietly erode because a company never built a policy response, is a retention failure with a real cost attached, not an abstract culture problem.

There's a disclosure angle too, one that's easy to miss. Once human capital resources are material to a company's business, and for most people-intensive businesses they are, a board that hasn't asked whether caregiving and menopause policy are being tracked and reported on is leaving a gap in its own oversight. That gap becomes visible fast if a shareholder proposal, an activist investor, or a regulator starts asking pointed questions about workforce retention data the company hasn't been collecting in the first place.

A Practical Framework

None of this requires a brand-new governance structure. It requires folding caregiving policy into the oversight mechanisms boards already have.

Treat it as human capital disclosure, not a side benefit. If retention, absenteeism, or leave usage tied to caregiving responsibilities is material to the business, it belongs in the same conversation as other human capital metrics reported to the board, not buried in a wellness newsletter nobody reads.

Name clear ownership. Someone, whether that's the CHRO, a compensation committee, or a dedicated human capital subcommittee, needs to be accountable for tracking and reporting on caregiving-related policy and outcomes, the same way someone owns cybersecurity risk reporting.

Track actual metrics, not intentions. Retention rates among employees aged 45 and older, leave utilization, and exit interview data tied to caregiving responsibilities all give a board something concrete to review, rather than a policy statement nobody can measure against.

Benchmark against where the law is heading, not just where it stands today. The UK's shift from voluntary to mandatory menopause action plans, and the expanding list of US states adding menopause protections, both suggest this is a direction of travel, not an isolated rule. Boards that get ahead of it avoid scrambling to build a policy under a compliance deadline.

Connect it to the broader ESG and human capital reporting the company already does. Caregiving policy fits naturally alongside other workforce metrics a company reports on, so there's rarely a need to build a separate reporting track from scratch, just to make sure this piece isn't left out of the existing one.

Frequently Asked Questions

Key Insights

• Menopause and eldercare responsibilities concentrate heavily among employees in their most experienced, senior-track years, making this a retention issue at the leadership level, not just an entry-level benefits question.

• The regulatory picture has moved fast in a short window, the UK's Employment Rights Act 2025, Rhode Island's 2025 law, and tightening SEC human capital disclosure expectations all landed close together.

• The financial exposure is measurable, eldercare-related productivity losses alone run into the tens of billions annually in the US.

• Boards that already have human capital oversight structures in place don't need new ones, they need to expand what those structures are tracking.

  
  

Key Takeaways

•  Caregiving policy belongs inside existing human capital disclosure and oversight, not off to the side as a wellness perk.

• Assign clear ownership and track measurable outcomes, retention, leave usage, absenteeism, tied to caregiving responsibilities.

• Watch the direction regulation is heading, from voluntary to mandatory, rather than waiting for a compliance deadline to force the issue.

• Treat this as a talent-retention and disclosure-risk matter, because that's exactly how investors and regulators are starting to treat it.

Effective corporate governance starts with understanding the workforce risks that shape business performance. Explore how board leadership, human capital oversight, and responsible governance can support long-term business success.

Join an upcoming Directors’ Institute webinar to gain insights into evolving governance priorities and strengthen your boardroom readiness.